Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Forty Seven, Inc. (FTSV) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Forty Seven, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1667633.
Total stock buying since 2018: $52,665,811.
Total stock sales since 2018: $49,682,745.
Total stock option exercises since 2018: $2,161,189.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2020 | 0 | $0 | 413,696 | $36,468,563 | 130,382 | $1,228,802 |
| 2019 | 1,375,000 | $11,000,000 | 690,522 | $12,865,728 | 214,187 | $873,791 |
| 2018 | 2,621,245 | $41,665,811 | 22,000 | $348,454 | 12,000 | $58,596 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2020-04 | 0 | $0 | 113,696 | $10,848,782 | 130,382 | $1,228,802 |
| 2020-03 | 0 | $0 | 250,000 | $23,591,907 | 0 | $0 |
| 2020-02 | 0 | $0 | 25,000 | $1,113,975 | 0 | $0 |
| 2020-01 | 0 | $0 | 25,000 | $913,899 | 0 | $0 |
| 2019-12 | 0 | $0 | 160,000 | $4,415,765 | 20,000 | $40,300 |
| 2019-11 | 0 | $0 | 20,000 | $216,415 | 0 | $0 |
| 2019-08 | 0 | $0 | 663 | $4,216 | 0 | $0 |
| 2019-07 | 1,375,000 | $11,000,000 | 0 | $0 | 0 | $0 |
| 2019-06 | 0 | $0 | 16,500 | $182,019 | 16,500 | $80,568 |
| 2019-05 | 0 | $0 | 28,811 | $415,367 | 24,500 | $96,689 |
| 2019-04 | 0 | $0 | 79,400 | $1,424,074 | 24,500 | $96,689 |
| 2019-03 | 0 | $0 | 73,216 | $1,282,129 | 24,500 | $96,689 |
| 2019-02 | 0 | $0 | 226,233 | $3,612,768 | 24,500 | $96,689 |
| 2019-01 | 0 | $0 | 85,699 | $1,312,975 | 79,687 | $366,167 |
| 2018-12 | 0 | $0 | 22,000 | $348,454 | 12,000 | $58,596 |
| 2018-08 | 300,900 | $4,540,291 | 0 | $0 | 0 | $0 |
| 2018-07 | 2,320,345 | $37,125,520 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-04-01 | Takimoto Chris H (Chief Medical Officer) | Sale | 79,195 | 95.42 | 7,556,786 |
| 2020-04-01 | Takimoto Chris H (Chief Medical Officer) | Option Ex | 79,195 | 11.34 | 897,675 |
| 2020-04-01 | Mccamish Mark Anthony (President and CEO) | Sale | 32,577 | 95.42 | 3,108,399 |
| 2020-04-01 | Mccamish Mark Anthony (President and CEO) | Option Ex | 30,237 | 4.88 | 147,647 |
| 2020-04-01 | Rhoads Ann D (Chief Financial Officer) | Sale | 1,924 | 95.42 | 183,597 |
| 2020-04-01 | Rhoads Ann D (Chief Financial Officer) | Option Ex | 20,950 | 8.76 | 183,480 |
| 2020-03-12 | Weissman Irving (Director) | Sale | 53,095 | 93.07 | 4,941,657 |
| 2020-03-11 | Weissman Irving (Director) | Sale | 196,905 | 94.72 | 18,650,250 |
| 2020-02-18 | Majeti Ravindra (Director) | Sale | 25,000 | 44.56 | 1,113,975 |
| 2020-01-15 | Majeti Ravindra (Director) | Sale | 25,000 | 36.56 | 913,899 |
| 2019-12-26 | Weissman Irving (Director) | Sale | 30,000 | 44.43 | 1,332,900 |
| 2019-12-16 | Majeti Ravindra (Director) | Sale | 25,000 | 35.60 | 890,075 |
| 2019-12-10 | Takimoto Chris H (Chief Medical Officer) | Sale | 10,000 | 35.00 | 350,000 |
| 2019-12-10 | Takimoto Chris H (Chief Medical Officer) | Option Ex | 10,000 | 2.02 | 20,150 |
| 2019-12-09 | Majeti Ravindra (Director) | Sale | 65,000 | 18.75 | 1,218,750 |
| 2019-12-09 | Takimoto Chris H (Chief Medical Officer) | Sale | 10,000 | 30.00 | 300,000 |
| 2019-12-09 | Takimoto Chris H (Chief Medical Officer) | Option Ex | 10,000 | 2.02 | 20,150 |
| 2019-12-09 | Weissman Irving (Director) | Sale | 20,000 | 16.20 | 324,040 |
| 2019-11-20 | Majeti Ravindra (Director) | Sale | 5,000 | 12.50 | 62,500 |
| 2019-11-18 | Majeti Ravindra (Director) | Sale | 15,000 | 10.26 | 153,915 |
| 2019-08-16 | Takimoto Chris H (Chief Medical Officer) | Sale | 663 | 6.36 | 4,216 |
| 2019-07-22 | Nieh Peter (10% Owner) | Buy | 625,000 | 8.00 | 5,000,000 |
| 2019-07-22 | Bird Jeffrey W (Director) | Buy | 750,000 | 8.00 | 6,000,000 |
| 2019-06-25 | Mccamish Mark Anthony (President and CEO) | Sale | 8,199 | 11.03 | 90,393 |
| 2019-06-25 | Mccamish Mark Anthony (President and CEO) | Option Ex | 8,199 | 4.88 | 40,035 |
| 2019-06-20 | Mccamish Mark Anthony (President and CEO) | Sale | 8,301 | 11.04 | 91,626 |
| 2019-06-20 | Mccamish Mark Anthony (President and CEO) | Option Ex | 8,301 | 4.88 | 40,533 |
| 2019-05-20 | Mccamish Mark Anthony (President and CEO) | Sale | 16,500 | 12.27 | 202,372 |
| 2019-05-20 | Mccamish Mark Anthony (President and CEO) | Option Ex | 16,500 | 4.88 | 80,569 |
| 2019-05-16 | Majeti Ravindra (Director) | Sale | 2,088 | 16.02 | 33,460 |
| 2019-05-15 | Majeti Ravindra (Director) | Sale | 2,223 | 16.01 | 35,583 |
| 2019-05-03 | Takimoto Chris H (Chief Medical Officer) | Sale | 8,000 | 17.99 | 143,952 |
| 2019-05-03 | Takimoto Chris H (Chief Medical Officer) | Option Ex | 8,000 | 2.02 | 16,120 |
| 2019-04-26 | Weissman Irving (Director) | Sale | 20,000 | 18.35 | 366,980 |
| 2019-04-18 | Mccamish Mark Anthony (President and CEO) | Sale | 16,500 | 18.12 | 299,062 |
| 2019-04-18 | Mccamish Mark Anthony (President and CEO) | Option Ex | 16,500 | 4.88 | 80,569 |
| 2019-04-15 | Majeti Ravindra (Director) | Sale | 25,000 | 18.30 | 457,500 |
| 2019-04-05 | Weissman Irving (Director) | Sale | 6,518 | 17.15 | 111,796 |
| 2019-04-04 | Takimoto Chris H (Chief Medical Officer) | Sale | 8,000 | 16.39 | 131,104 |
| 2019-04-04 | Takimoto Chris H (Chief Medical Officer) | Option Ex | 8,000 | 2.02 | 16,120 |
| 2019-04-03 | Weissman Irving (Director) | Sale | 3,382 | 17.04 | 57,632 |
| 2019-03-29 | Weissman Irving (Director) | Sale | 100 | 18.00 | 1,800 |
| 2019-03-26 | Weissman Irving (Director) | Sale | 10,000 | 15.98 | 159,810 |
| 2019-03-19 | Majeti Ravindra (Director) | Sale | 5,292 | 18.03 | 95,398 |
| 2019-03-19 | Mccamish Mark Anthony (President and CEO) | Sale | 16,500 | 18.15 | 299,409 |
| 2019-03-19 | Mccamish Mark Anthony (President and CEO) | Option Ex | 16,500 | 4.88 | 80,569 |
| 2019-03-18 | Majeti Ravindra (Director) | Sale | 9,708 | 18.02 | 174,938 |
| 2019-03-15 | Majeti Ravindra (Director) | Sale | 20,000 | 17.68 | 353,620 |
| 2019-03-04 | Takimoto Chris H (Chief Medical Officer) | Sale | 8,000 | 16.94 | 135,552 |
| 2019-03-04 | Takimoto Chris H (Chief Medical Officer) | Option Ex | 8,000 | 2.02 | 16,120 |
| 2019-03-01 | Weissman Irving (Director) | Sale | 3,616 | 17.04 | 61,602 |
| 2019-02-27 | Weissman Irving (Director) | Sale | 4,280 | 17.01 | 72,807 |
| 2019-02-26 | Weissman Irving (Director) | Sale | 12,104 | 16.93 | 204,969 |
| 2019-02-25 | Majeti Ravindra (Director) | Sale | 30,798 | 16.07 | 494,985 |
| 2019-02-25 | Weissman Irving (Director) | Sale | 10,000 | 17.03 | 170,330 |
| 2019-02-22 | Majeti Ravindra (Director) | Sale | 67,113 | 16.01 | 1,074,411 |
| 2019-02-20 | Mccamish Mark Anthony (President and CEO) | Sale | 9,410 | 14.94 | 140,547 |
| 2019-02-20 | Mccamish Mark Anthony (President and CEO) | Option Ex | 9,410 | 4.88 | 45,949 |
| 2019-02-19 | Takimoto Chris H (Chief Medical Officer) | Sale | 2,500 | 15.05 | 37,622 |
| 2019-02-19 | Mccamish Mark Anthony (President and CEO) | Sale | 7,090 | 15.06 | 106,796 |
| 2019-02-19 | Mccamish Mark Anthony (President and CEO) | Option Ex | 7,090 | 4.88 | 34,620 |
| 2019-02-04 | Takimoto Chris H (Chief Medical Officer) | Sale | 8,000 | 14.86 | 118,872 |
| 2019-02-04 | Takimoto Chris H (Chief Medical Officer) | Option Ex | 8,000 | 2.02 | 16,120 |
| 2019-02-04 | Weissman Irving (Director) | Sale | 6,445 | 15.02 | 96,803 |
| 2019-02-01 | Weissman Irving (Director) | Sale | 3,219 | 15.02 | 48,362 |
| 2019-01-31 | Majeti Ravindra (Director) | Sale | 3,834 | 14.57 | 55,872 |
| 2019-01-30 | Majeti Ravindra (Director) | Sale | 16,166 | 14.46 | 233,679 |
| 2019-01-28 | Weissman Irving (Director) | Sale | 336 | 15.00 | 5,040 |
| 2019-01-25 | Mccamish Mark Anthony (President and CEO) | Option Ex | 51,687 | 4.88 | 252,387 |
| 2019-01-18 | Mccamish Mark Anthony (President and CEO) | Sale | 20,000 | 14.60 | 291,900 |
| 2019-01-18 | Mccamish Mark Anthony (President and CEO) | Option Ex | 20,000 | 4.88 | 97,660 |
| 2019-01-16 | Majeti Ravindra (Director) | Sale | 4,363 | 16.00 | 69,821 |
| 2019-01-15 | Majeti Ravindra (Director) | Sale | 23,000 | 15.73 | 361,813 |
| 2019-01-09 | Weissman Irving (Director) | Sale | 10,000 | 17.05 | 170,490 |
| 2019-01-04 | Takimoto Chris H (Chief Medical Officer) | Sale | 8,000 | 15.54 | 124,360 |
| 2019-01-04 | Takimoto Chris H (Chief Medical Officer) | Option Ex | 8,000 | 2.02 | 16,120 |
| 2018-12-26 | Mccamish Mark Anthony (President and CEO) | Sale | 12,000 | 15.90 | 190,764 |
| 2018-12-26 | Mccamish Mark Anthony (President and CEO) | Option Ex | 12,000 | 4.88 | 58,596 |
| 2018-12-26 | Weissman Irving (Director) | Sale | 10,000 | 15.77 | 157,690 |
| 2018-08-23 | Mhatre Ravi (10% Owner) | Buy | 56,858 | 15.27 | 868,278 |
| 2018-08-22 | Mhatre Ravi (10% Owner) | Buy | 110,000 | 14.97 | 1,647,140 |
| 2018-08-17 | Nieh Peter (10% Owner) | Buy | 2,500 | 14.96 | 37,400 |
| 2018-08-16 | Nieh Peter (10% Owner) | Buy | 65,000 | 15.19 | 987,480 |
| 2018-08-16 | Schaepe Christopher J (Director) | Buy | 66,542 | 15.03 | 999,993 |
| 2018-07-02 | Liew Jeremy (10% Owner) | Buy | 468,750 | 16.00 | 7,500,000 |
| 2018-07-02 | Pullara Samuel J Iii (Other) | Buy | 136,794 | 16.00 | 2,188,704 |
| 2018-07-02 | Dyckerhoff Stefan A (Other) | Buy | 136,650 | 16.00 | 2,186,400 |
| 2018-07-02 | Speiser Michael L (10% Owner) | Buy | 140,480 | 16.00 | 2,247,680 |
| 2018-07-02 | Wheeler Kurt (10% Owner) | Buy | 200,000 | 16.00 | 3,200,000 |
| 2018-07-02 | Bird Jeffrey W (Director) | Buy | 138,987 | 16.00 | 2,223,792 |
| 2018-07-02 | Henner Dennis (Director) | Buy | 200,000 | 16.00 | 3,200,000 |
| 2018-07-02 | White James N (10% Owner) | Buy | 142,150 | 16.00 | 2,274,400 |
| 2018-07-02 | Coxe Tench (10% Owner) | Buy | 153,049 | 16.00 | 2,448,784 |
| 2018-07-02 | Schaepe Christopher J (Director) | Buy | 468,750 | 16.00 | 7,500,000 |
| 2018-07-02 | Sutter Hill Ventures (Other) | Buy | 134,735 | 16.00 | 2,155,760 |
Insider trading activities including stock purchases, stock sales, and option exercises of FTSV listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Forty Seven, Inc. (symbol FTSV, CIK number 1667633) see the Securities and Exchange Commission (SEC) website.